Perturbation of CaMKIIβ expression has been associated with multiple neuropsychiatric diseases, highlighting CaMKIIβ as a gene of interest. Yet, in contrast to CaMKIIα, the specific functions of CaMKIIβ in the brain remain poorly explored. Here, we reveal a novel function for this CaMKII isoform in vivo during neuronal development. By using in utero electroporation, we show that CaMKIIβ is an important regulator of radial migration of projection neurons during cerebral cortex development. Knockdown of CaMKIIβ causes accelerated migration of nascent pyramidal neurons, whereas overexpression of CaMKIIβ inhibits migration, demonstrating that precise regulation of CaMKIIβ expression is required for correct neuronal migration. More precisely, CaMKIIβ controls the multipolar-bipolar transition in the intermediate zone and locomotion in the cortical plate through its actin-binding and -bundling activities. In addition, our data indicate that a fine-tuned balance between CaMKIIβ and cofilin activities is necessary to ensure proper migration of cortical neurons. Thus, our findings define a novel isoform-specific function for CaMKIIβ, demonstrating that CaMKIIβ has a major biological function in the developing brain.
Introduction
During brain development, neurons migrate extensively after their birth to reach their final destination, where they establish connections with other neurons and contribute to circuit formation. Several psychiatric and neurological diseases are considered as neurodevelopmental disorders because they result from abnormal neuronal development, especially from defects in neuronal migration, thereby underscoring the importance of this process for normal brain function [1] [2] [3] . Unraveling the complexities of neuronal migration is thus essential to our understanding of both normal cortical development and neurodevelopmental disorders.
In the developing cerebral cortex, newborn pyramidal neurons undergo radial migration to reach their correct position within the cortical plate (CP) [4] . Radial migration is a multi-phasic process starting with the detachment of newly born neurons from the apical surface of the germinal ventricular zone (VZ). Nascent neurons then move to the intermediate zone (IZ) where they acquire a multipolar shape [5] . Thereafter, neurons become bipolar, extending a leading process toward the pial surface and a trailing process in the opposite direction. Upon multi to bipolar transition, neurons establish dynamic contacts with radial glia fibers and subsequently use them as a scaffold to migrate to the upper part of the CP using a mode of migration called locomotion [6] . This movement is characterized by repetitive cycles of synchronized steps-formation of a cytoplasmic dilatation in the proximal region of the leading process, movement of the centrosome towards the swelling and translocation of the nucleus toward the centrosomeconferring a saltatory advancement to locomoting neurons [7, 8] . Finally, once neurons approach their final location, they change again their mode of migration from locomotion to terminal translocation and finally settle in a specific cortical layer [9] .
The locomotion mode of neuronal migration covers the largest part of the neuronal journey in the developing cerebral cortex. This process requires a dynamic cellular remodeling, which largely depends on the coordinated activity of the actin and microtubule cytoskeletons [6, [10] [11] [12] . More precisely, the coordination between the centrosome and the nucleus depends on the microtubule network that couples these two organelles, including the perinuclear cage that surrounds the nucleus [13] . Actin filaments, which are enriched in the proximal portion of the leading process, are essential for the formation of the proximal cytoplasmic dilation in the leading process [14] and also provide a major driving force for the coordinated movement of the centrosome and soma during neuronal migration [15, 16] . The actomyosin-based contraction at the cell rear might also provide additional forces to promote forward nuclear movement [16] . Although the cytoskeleton is clearly involved in the dynamic changes occurring during locomotion but also during the multipolar-bipolar transition [17] , it is still largely unknown how cytoskeleton components are regulated and coordinated during these processes. Thus, identification of new cytoskeleton regulators is fundamental to shed light on the molecular mechanisms responsible for proper cortical neuron migration.
The calcium/calmodulin-dependent protein kinase II (CaMKII) is a predominant protein in the brain, accounting for 1-2% of total brain proteins [18] . Because of this abundance and as major player in Ca 2+ signaling, CaMKII represents a critical link between the external environment and cellular responses in neurons. There are four isoforms of CaMKII (α, β, γ and δ) encoded by separate genes. CaMKII exists as a holoenzyme composed of 12 subunits, which form a complex through their association domains. Brain CaMKII predominantly consists of the α and β isoforms, which form heteromeric or homomeric complexes [19] . Although the brain functions of CaMKIIα have been extensively studied [20, 21] , the isoform-specific functions of CaMKIIβ are less characterized and remain largely undefined in vivo. Interestingly, this isoform is expressed in the embryonic cerebral cortex whereas the α isoform is absent [22, 23] , interacts directly with the actin cytoskeleton [24] and its expression is modified in neuropsychiatric illnesses including schizophrenia [25, 26] . In view of these data suggesting that CaMKIIβ might have unique and important roles in cortical development, we have investigated its contribution to cerebral corticogenesis. Importantly, we have discovered a key role for this isoform in regulating radial migration of projection neurons. In particular, we demonstrate that CaMKIIβ is a critical element not only for the transition between the multipolar and the bipolar stage but also for the saltatory movement of locomoting neurons. This activity is dependent on its actinbinding and -bundling properties.
Materials and methods

Animals
Time pregnant CD1 females were housed, bred and treated according to the European directive 2010/63/EU, French laws on animal experimentation and according to the guidelines approved by the Home Office under the Animal (Scientific Procedures) Act 1986.
Plasmid constructs
CaMKIIβ#1 short hairpin RNA (shRNA) and CaMKIIβ#2 shRNA were obtained by cloning the following sequences into the short hairpin RNA vector, pCA-b-EGFPm5 silencer 3 (generous gift from Dr. Vermeren): CaMKIIβ#1, 5ʹ-GTCCGACGCTGTGTCAAGC-3ʹ [27] ; CaMKIIβ#2, 5ʹ-GAGTATGCAGCCAAGATCA-3ʹ [28] adapted to mouse sequence. Control (ctrl) shRNA construct was generated by cloning into pCA-b-EGFPm5 silencer 3, a 19-bp scrambled sequence (5ʹ-TACGCGCATAAGATTAGGG-3ʹ) with no significant homology to any known gene sequence from mouse or human as previously described [29] .
CaMKIIβ cloned into the pEGFP-C1 vector (with a CMV promoter) was a kind gift from Dr. Paul De Koninck, CaMKIIβ-ΔFABD, CaMKIIβ-Δasso, CaMKIIβ-K43R and CaMKIIβ-ΔCTS cloned into the pEGFP-C1 vector from Dr. Azad Bonni, CaMKIIβ-All A and CaMKIIβ-All D cloned into the pEGFP-C1 vector from Dr. Yasunori Hayashi, pcDNA-cofilinS3D, pcDNA-cofilinS3A and pcDNAcofilinWT from Iryna M. Ethell and pCIG2-Centrin2-Venus construct from Dr. Mary E. Hatten.
CaMKIIβ, CaMKIIβ-ΔFABD, CaMKIIβ-Δasso, CaM-KIIβ-K43R, CaMKIIβ-ΔCTS, CaMKIIβ-All A and CaMKIIβ-All D were cloned by PCR using pEGFP-C1 constructs as template and then inserted into the XhoI/EcoRI sites of the pCIG2 vector to generate pCIG-CaMKIIβ and the different mutants.
To generate expression constructs harboring silent point mutations in the sequence recognized by CaMKIIβ#1 shRNA (marked CaMKIIβ*), site-directed mutagenesis was performed using QuickChange II Site-Directed Mutagenesis Kit (Stratagene) on pEGFPC1-CaMKIIβ plasmid or mutant constructs using the following primers: forward, 5ʹ-CTTTCTCTGTGGTGCGACGGTGTGTGAAGCTCTGT ACCG-3ʹ and reverse, 5ʹ-CGGTACAGAGCTTCACA CACCGTCGCACCACAGAGAAAG-3ʹ. The underlined nucleotide residues identify silent mutations on nt84(C → G), nt90(C → G) and nt96(C → G) of the CaMKIIβ complementary DNA (cDNA) sequence.
CaMKIIβ was cloned by PCR into the XhoI site of the dephosphorylated pNeuroD1-IRES-GFP expression plasmid to generate pND-CaMKIIβ.
All of the above-mentioned constructs were fully sequenced verified before their use in experiments.
In utero electroporation and tissue processing
In utero electroporation of the cerebral cortex was performed at E14.5 as previously described [30, 31] . A concentration of 1 µg/µl was used for each construct. At the desired time point after electroporation, pregnant mice were sacrificed by neck dislocation and embryos were processed for tissue analyses. Embryonic brains were fixed in 4% paraformaldehyde (PFA) overnight and then placed in 20% sucrose/phosphate-buffered saline (PBS) overnight. Brains were then embedded in OCT Compound (VWR International) and frozen before sectioning using a cryostat (14 µm) . For analysis at postnatal day 14 (P14) and 8 weeks, brains were removed from anesthetized pups subjected to intracardiac perfusion of PBS followed by 4% PFA in PBS. Brains were then post-fixed in 4% PFA and cut with a vibratome (40 µm).
For migration analysis, the different subregions of the cerebral cortex (VZ/subventricular zone (SVZ), IZ and CP) were identified based on cell density and visualized with TOTO-3 iodide nuclear staining (Invitrogen) [30] . Images were acquired with a confocal microscope (Leica SP5 or SP8). For migration experiments, at least six sections were analyzed for each condition from at least three embryos or pups from two or three litters obtained in parallel experiments. Cell counts were performed using MetaMorph software.
For morphometrical analysis, dendrites of electroporated neurons were traced using a 100× objective and a semiautomatic neuron tracing system (Neurolucida; MicroBrightField).
Leading process width was measured by drawing a transversal line at the portion of the leading process adjacent to the nucleus with ImageJ [32] as previously described [33] . For this analysis, cells exhibiting a nucleus with a round shape were selected.
Ex vivo cortical electroporation and live imaging
Ex vivo electroporation and live imaging were performed as previously described [29, 30] . Ex vivo electroporation was performed on injected mouse embryos' heads similarly to in vivo electroporation. The electrical parameters were the following: 50 V, 50 ms length, 5 pulses, 1-s interval. Following electroporation, brains were dissected in L15 (PAA Laboratories) and transferred into liquid 3% low melting agarose (Sigma) and incubated on ice. Embedded brains were cut coronally (300 μm) with a vibratome (Leica), and slices were transferred onto sterilized culture plate inserts (0.4-μm pore size; Millicell-CM, Millipore) and cultivated in complete Neurobasal containing Neurobasal medium (Gibco) supplemented with 1% B27, 1% N2, 1% glutamine, 1% penicillin/streptomycin and 1% fungizone.
Thirty hours after ex vivo electroporation, green fluorescent protein (GFP) was imaged in live brain slices using 900 nm multiphoton excitation (Spectraphysics MaiTai DeepSee) with a Leica SP5 confocal scanner on a DM6000 CFS upright microscope. A 10×, 0.4 NA (dry) objective was used and reflected excitation collected with a non descanned PMT through a 525/50 filter (Semrock).
Movies were analyzed using the Fiji software [34] . Three dimensional sample drift over time was corrected with the Correct 3D drift plug-in and cell movement was analyzed using the Manual Tracking plug-in.
Immunostaining
After washing in PBS, sections or fixed cells (with PFA 4%, 10 min at room temperature) were treated with PBS-0.01% Triton X-100-10% serum for 30 min. They were then incubated overnight at 4°C with the following primary antibodies diluted in the blocking buffer: rabbit anti-CaMKIIβ (1/ 300; Abcam, ab34703), mouse anti-CaMKIIδ (1/50, Santa Cruz, sc-100362), mouse anti-CaMKIIγ (1/50, Santa Cruz, sc-517278), rabbit anti-Cux1 (1/50; Santa Cruz, sc-13024), chicken anti-GFP (1/1000; Abcam, ab13970), mouse antiKi67 (1/50; BD Pharmingen TM , 550609), mouse anti-NeuN (1/500; Millipore, MAB377), rabbit anti-pHH3 (1/200; Upstate, 06-570), rabbit anti-Tbr2 (1/500; Abcam, ab23345), mouse anti-Tuj1 (1/200; Covance, MMS-435P). Sections were then incubated with appropriate fluorescent secondary antibodies. For Cux1 and NeuN immunostainings, a step of antigen retrieval with citrate was performed before the step of blocking (sodium citrate pH = 6 for 15 min at 90°C).
Filamentous-actin (F-actin) filaments were visualized using rhodamine-labeled phalloidin (Sigma). After fixation, sections or cells were permeabilized 10 min with 0.1% Triton X-100-PBS, incubated with rhodamine-labeled phalloidin diluted in PBS (0.2 µg/ml) for 40 min and washed several times in PBS.
RNA in situ hybridization
Embryonic brains were dissected in 1 × PBS and fixed overnight in 4% PFA/1 × PBS at 4°C. Fixed samples were cryoprotected overnight in 20% sucrose/1 × PBS at 4°C, mounted in OCT Compound and sectioned coronally with a cryostat (14 µm). Nonradioactive RNA in situ hybridizations on frozen brain sections were performed with digoxigenin-labeled riboprobes as described previously [35] . The RNA sense and antisense probes for CaMKIIβ were kindly provided by Dr. Franck Oury [36] .
Cell culture
Mouse embryonic teratocarcinoma P19 cells were cultured in high glucose Dulbecco's modified Eagle's medium (DMEM) (Sigma) supplemented with 10% fetal bovine serum, 2 mM glutamine and 1% penicillin/streptomycin. Cells were plated in 24-well plates and incubated at 37°C under 5% CO 2 atmosphere. One day after plating, P19 cells were transfected with Lipofectamine 2000 reagent according to the manufacturer's protocol (Invitrogen). Twentyfour hours post-transfection, cells were collected for RNA or protein extraction.
Primary cortical neuron cultures were prepared from E13.5 or E14.5 mouse cortices. Cortices were dissected in Hepes 0.1 M and then incubated for 15 min in trysin-EDTA (0.125%). After two washings in Hepes 0.1 M, tissues were either dissociated in Optimem containing Lipofectamine and DNA (for transfection) or dissociated in Neurobasal medium (Gibco) supplemented with 2% B27, 1% N2, 2 mM glutamine and 1% penicillin/streptomycin (for F-actin precipitation). Dissociated cortical cells were seeded on poly-Dlysine (25 μg/ml, Sigma) coated wells and cultured in complete neurobasal medium for 4 or 5 days.
F-actin precipitation
F-actin was isolated from cerebral cortices (E17.5) or neuronal cell cultures (E14+5DIV) after modification of a published protocol [37] . Four cortices for each condition were dissected and transferred into 1 ml of homogenization buffer (100 mM Na 2 HPO 4 -100 mM NaH 2 PO 4 at pH 7.2, 2 mM ATP, 2 mM MgCl 2 , 0.1% Triton X-100) containing phosphatase and protease inhibitor cocktails (Sigma). For analysis on cultures, 16 wells of 24-well plates were pooled for each condition. When needed, cells were incubated for 10 min with 10 µM of the calcium ionophore A23187 (Tocris) before the lysis. Neurons were then lysed and homogenized, like tissues, at 4°C into 1 ml of homogenization buffer by pipetting up and down using a 18G needle. Biotinylated phalloidin (1 unit for each condition, Invitrogen) was then added to homogenates and incubated under rotation for 1 h at room temperature. In parallel, streptavidin-coated magnetic beads (50 µl for each condition; Invitrogen) were blocked for 30 min in PBS (Sigma) with 5% bovine serum albumine (Sigma), washed and added to homogenates with biotinylated phallodin for 1 h at room temperature. The precipitated material was then washed five times with homogenization buffer, resuspended in 1× laemmli sample buffer (Bio-Rad) and analyzed by western blotting using primary antibodies against actin and CaMKIIβ according to the protocol described below.
Measurement of G/F-actin ratio by Triton X-100 fractionation
The measurement of monomeric (Triton soluble) and polymerized (Triton insoluble) actin in transfected P19 cells was performed as previously described [38] with minor modifications. Briefly, cells were gently washed with a cytoskeleton stabilization buffer containing 0.1 M MES (pH 6.75), 1 mM MgSO 4 , 2 mM EGTA, 0.1 mM EDTA, 4 M glycerol. Cells were then incubated with the cytoskeleton stabilization buffer supplemented with 0.1% Triton X-100 and protease inhibitors (Sigma) for 6 min at 37°C. The supernatant containing G-actin was collected and centrifuged at 10,000 g for 2 min at 4°C to remove debris. Extraction of the Triton-insoluble fraction remaining on the culture plate was performed in lysis buffer containing 25 mM Tris (pH 6.8), 0.5% sodium dodecyl sulfate (SDS) and supplemented with protease inhibitors. Cells were scraped off and incubated in the lysis buffer for 30 min on ice to extract F-actin. Actin levels were quantified by immunoblot using a rabbit anti-actin antibody (1/2000; Sigma, A2066). For each condition, we pooled four wells of a 24-well plate. Densitometry was performed using Odyssey software (LI-COR).
Protein extraction
Cerebral cortices were dissected and dissociated using a 18G needle in 100 µl of a solution containing 20 mM HEPES, 0.15 mM NaCl, 1% Triton X-100, 1% deoxycholic acid, 1% SDS (pH 7.5) and supplemented with phosphatase and protease inhibitor cocktails. Similar buffer was used to extract proteins from cells. After incubation for 1 h at 4°C, samples were centrifuged at 10,000 g for 15 min. Supernatant was isolated and used as total protein extracts. Protein amounts were quantified using the Bradford's protein assay (Bio-Rad).
Western blotting
Electrophoresis was performed on precast 4-15% polyacrylamide Tris-Glycine gels (Bio-Rad). Protein levels were normalized to 50 µg of protein per sample and resuspended with 4× laemmli sample buffer (Bio-Rad) before boiling (5 min at 95°C). Then, proteins were transferred onto a polyvinylidenedifluoride membrane (Bio-Rad). Membranes were blocked with Tris-Tween buffered solution (TTBS; 10 mM Tris, 200 mM NaCl, 0.05% Tween 20, pH 7.4) containing 5% non-fat dry milk for 1 h at room temperature. For F-actin precipitation studies, blots were then incubated overnight at 4°C with a mouse anti-CaMKII beta antibody (0,5 µg/mL; Thermofisher, 139800) and a rabbit anti-actin antibody (1/2000; Sigma, A2066). For variant expression analysis, blots were incubated with a rabbit anti-CaMKIIβ (1/1000; Abcam, ab34703). Primary antibodies were probed with a IRDye 800CW goat anti-rabbit IgG together with a IRDye 680RD goat anti-mouse IgG (Li-Cor Biosciences) during 1-h incubation at room temperature. After three washes with TTBS and one with PBS, membrane was scanned using the automated infrared imaging system Odyssey (Li-Cor Biosciences) according to manufacturer's instructions.
Quantitative real-time PCR (qPCR)
Cell and tissue samples were homogenized in Tri-reagent (Euromedex) and RNA was isolated using a standard chloroform/isopropanol protocol. RNA was processed and analyzed following an adaptation of published methods [39] . cDNA was synthesized from 2 μg of total RNA using RevertAid Premium Reverse Transcriptase (Fisher Scientific) and primed with oligo-dT primers (Fisher Scientific) and random primers (Fisher Scientific). qPCR was performed using a LightCycler® 480 Real-Time PCR System (Roche). qPCR reactions were done in duplicate for each sample, using transcript-specific primers (Table 1) , cDNA and LightCycler 480 SYBR Green I Master mix (Roche) in a final volume of 10 μl. PCR data were exported and analyzed in the GEASE software (Gene Expression Analysis Software Environment) developed in the Neurocentre Magendie (https://bioinfo.neurocentre-magendie.fr/outils/ GEASE/). For the determination of the reference genes, the GeNorm method was used [40] . Relative expression analysis was corrected for PCR efficiency and normalized against two reference genes. The relative level of expression was calculated using the comparative (2-ΔΔCT) method [40] .
Statistical analysis
Statistical analyses were performed using the GraphPad Prism software. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those generally employed in the field. Molecular and biochemical analyses were performed using a minimum of three biological replicates per condition. Results are presented as mean ± s.e.m. The statistical test used for each experiment, as well as sample size (n) are described in the corresponding figure legend.
Results
CaMKIIβ is expressed in post-mitotic cortical neurons and interacts with F-actin
We began this study by examining the expression of CaMKIIβ in the mouse developing cerebral cortex. We first showed by real-time PCR that CaMKIIβ expression increases significantly between E12.5 and postnatal day 0 (P0) (Fig. 1a and Supplementary Figure 1b) , whereas CaMKIIα transcripts are poorly expressed until birth (Supplementary Figure 1a ). By RNA in situ hybridization on coronal brain sections, we then found that CaMKIIβ transcripts are detected mainly in the CP at different developmental stages (Fig. 1b and Supplementary Figures 1d-e) and uniformly along the rostrocaudal axis ( Supplementary Figure 1c) . Immunostainings performed on E17.5 brains showed that CaMKIIβ is expressed in post-mitotic neurons, as identified by staining with the neuron-specific β-tubulin III marker Tuj1 (Fig. 1c) , in the upper part of the IZ and in the CP. Stainings also indicate that CaMKIIβ is expressed in multipolar and locomoting neurons ( Supplementary Figures 1f and g ). The four splice variants of CaMKIIβ (CaMKIIβ, β', βe, β'e) are expressed in the developing cerebral cortex ( Fig. 1d and Supplementary Figures 1h-k) and their protein levels increase significantly between E14.5 and P0 (Fig. 1d ). In addition, CaMKIIβ interacts with Factin in nascent cortical neurons (Figs. 1e-h), suggesting altogether that CaMKIIβ might play a role in cytoskeletal remodeling in radially migrating cortical neurons.
CaMKIIβ knockdown promotes radial migration of cortical neurons
To determine whether CaMKIIβ regulates radial migration of projection neurons, we used an acute loss-of-function approach by RNA interference. We designed two shRNAs that efficiently knocked down CaMKIIβ expression by targeting distinct regions of CaMKIIβ mRNA ( Supplementary  Figures 2 and 3b) . Importantly, CaMKIIβ silencing in cortical neurons had no impact on the expression of the two other isoforms expressed in the embryonic brain [22] , CaMKIIδ and CaMKIIγ (Supplementary Figure 3) . We then introduced the two CaMKIIβ shRNAs together with Enhanced Green Fluorescent Protein (EGFP) expressed from the same construct by in utero electroporation in the cerebral cortex at E14.5. Electroporation of CaMKIIβ shRNA in the cortex did not induce cell death or defects in radial glia processes and did not alter neural progenitor proliferation, as well as neuronal output (Supplementary Figure 4 and data not shown). However, 3 days after electroporation (E17.5), the distribution of electroporated cells in the different zones of the cortex was quantified and this analysis revealed that CaMKIIβ silencing caused an acceleration of migration into the CP (Figs. 2a, b) . Indeed almost 60% of cells electroporated with CaMKIIβ#1 shRNA at E14 already entered the CP after 3 days, in contrast to 51% in control condition (Fig. 2b) . In addition, most of the cells in the CP reached the upper part of this region (uCP) after CaMKIIβ knockdown (26.8 ± 1.9% of CaMKIIβ#1 shRNAelectroporated cells compared with 18.5 ± 1.6% of control shRNA-electroporated cells; Fig. 2b ). There was no significant difference in the VZ/SVZ and the morphology of radially migrating neurons was unaffected by CaMKIIβ depletion neither in the CP nor in the IZ (Supplementary Figure 5a) . To confirm our observations in fixed sections, we performed live imaging experiments to track migration of neurons expressing control or CaMKIIβ#1 shRNA, the most efficient and specific CaMKIIβ shRNA ( Supplementary  Figures 2a and 3b ). shRNAs were introduced by ex vivo electroporation into the developing cortex at E14.5, brain sections were prepared and imaged 30 h later. In accordance with our previous results, we found that CaMKIIβ-deficient cells moved faster in the CP (Supplementary Movie 1) with a mean speed value of 19.6 ± 1.1 µm/h compared with 13.3 ± 1.1 µm/h in control cells (Figs. 2c, d ). We then analyzed in more details the migration profiles of these neurons that had adopted a bipolar shape and were migrating in the CP (Supplementary Figures 5b-g ). A saltatory step was defined as any increase in speed surrounded on both sides by periods of zero speed (=pauses) as previously described [41] . Our quantifications indicated that CaMKIIβ silencing reduced significantly the number of pauses ( Supplementary  Figure 5f ) and the number of saltatory steps per hour (Supplementary Figure 5b) . In addition, the duration of the saltatory step in this condition was increased, as well as the speed and the distance traveled during this forward movement (Supplementary Figures 5c-e) . The reduction in pausing frequency after CaMKIIβ knockdown together with the increased migration speed during the salutatory steps might explain the accelerated migration of neurons in this condition. Moreover, as a result of this pause reduction, the movement of CaMKIIβ-silenced cells toward the upper part of the CP appeared less saltatory (Supplementary Movies 2-3) but instead more continuous compared with control cells (Supplementary Movies 4 and 8) [29] . We also analyzed the dynamic multipolar-bipolar transition of cortical neurons and found that CaMKIIβ knockdown favors this process (Fig. 2e) . Accordingly, 2 days after the electroporation, when most electroporated cells are located in the VZ/SVZ and in the IZ in control condition, we observed that CaM-KIIβ silencing increased significantly the ratio of GFP + cells in the CP, in particular in the lower CP (lCP) and median CP (mCP) (Supplementary Figures 5h and i) . Therefore, when CaMKIIβ is silenced, neurons quickly leave the IZ after the multipolar-bipolar transition to reach the CP. This might explain why the proportion of multipolar-bipolar cells is not significantly affected after CaMKIIβ knockdown (Supplementary Figure 5a) . CaMKIIβ silencing then promotes the locomotion of cortical neurons in the CP, which also contributes to the acceleration of migration. Figure 1 Analyses conducted at P14, showed that CaMKIIβ-depleted neurons finally reached their terminal destination properly (Supplementary Figures 5j and k) but exhibited longer, more branched dendrites compared with control neurons (Supplementary Figures 6a-d ), an effect already described in primary cerebral cortical neurons [27] . Changes in the dendritic arborization of CaMKIIβ-silenced projection neurons were still observed in adult mice (Supplementary Figures 6e-h ) indicating that CaMKIIβ knockdown during embryonic development impacts neuronal morphology in the adult brain. Thus, CaMKIIβ silencing in nascent cortical neurons perturbs different aspects of corticogenesis and has a long-term impact on the brain.
CaMKIIβ overexpression alters migration of cortical projection neurons
Because CaMKIIβ knockdown promotes cortical neuron migration, we investigated whether conversely overexpression of CaMKIIβ impairs this process. CaMKIIβ was overexpressed at high level (pCIG-CaMKIIβ) in E14.5 cerebral cortices by in utero electroporation together with a plasmid encoding GFP (Supplementary Figures 7 and 8a) . Importantly, CaMKIIβ overexpression did not modify CaM-KIIδ and CaMKIIγ expression levels in cortical neurons (Supplementary Figure 8) . Examination of the electroporated brains at E17.5 revealed a marked defect in the migration of CaMKIIβ-expressing cells compared with control cells (Fig. 3a) . Indeed CaMKIIβ expression resulted in a significant decrease in the fraction of cells reaching the CP (44.1 ± 3.2% of CaMKIIβ electroporated cells compared with 55.9 ± 1.0% of control cells) and particularly the upper part of the CP (9.1 ± 0.9% vs. 25.6 ± 1.9%), whereas the fraction in the IZ was concomitantly increased (36.9 ± 3.0% vs. 27.2 ± 1.6%; Fig. 3b ). Additional studies with CaMKIIβ expression at lower levels with CMV or NeuroD promoters indicated that the extent of the migration defects correlates with the degree of CaMKIIβ overexpression (Supplementary Figures 9a and   b) . A closer look at the cortical wall revealed that CaMKIIβ overexpression increased the proportion of multipolar cells in the IZ at the expense of uni/bipolar cells while migrating neurons in the CP did not show grossly affected morphology (Fig. 3c) . These observations were corroborated by our live imaging studies indicating that CaMKIIβ expression in cortical cells impaired the multipolar-bipolar conversion (Fig. 3d) and reduced migration speed in the CP (8.6 ± 0.6 µm/h vs. 11.5 ± 0.9 µm/h) (Supplementary Movie 5, Figs. 3e, f) Moreover CaMKIIβ overexpression reduced the distance traveled during a saltatory step (Supplementary Figure 9e) , an effect that can be visualized in movies of isolated CaMKIIβ-expressing cells (Supplementary Movies 6-8) .
We then investigated whether the early overexpression of CaMKIIβ affects neuronal positioning at postnatal stage. At P14, we quantified the proportion of electroporated cells in 10 arbitrarily defined layers of the same size along the cortex. Although many CaMKIIβ-expressing cells finally reached their terminal position in bins 7 and 8, there was still a significant fraction of cells packed in lower bins, suggesting that CaMKIIβ levels critically determine the migratory behavior of cortical cells (Figs. 3g, h ). However, the neurons trapped in deep layers expressed the upper layer marker Cux1 indicating that CaMKIIβ expression impairs migration but not laminar specification ( Supplementary  Figure 9i and j) .
The proliferation of cortical progenitors, the rate of cell death and the organization of the radial glia scaffold remained unperturbed, indicating that CaMKIIβ overexpression interferes specifically and cell autonomously with neuronal migration ( Supplementary Figures 9k and l; data not shown). Altogether, the aforementioned results show that normal CaMKIIβ levels are required for correct radial migration in the embryonic cerebral cortex.
CaMKIIβ activity in locomoting neurons requires its F-actin-binding and multimerization domains
The identification of a novel role for CaMKIIβ in the control of neuronal migration led us to determine the molecular basis of CaMKIIβ function in migrating cortical neurons. To this goal, we asked whether mutations in specific regions of CaMKIIβ could abolish its deleterious effect on radial migration. First, to test the contribution of kinase activity in the regulation of neuronal migration, we used a catalytically inactive mutant of CaMKIIβ (K43R) ( Supplementary Figure 10a) . Overexpression of this mutated form of CaMKIIβ impaired radial migration similarly to wild-type CaMKIIβ suggesting that the migration defects induced by CaMKIIβ overexpression do not involve the catalytic activity of the kinase (Figs. 4a, b) . In contrast to CaMKIIα, CaMKIIβ harbors, within the N-terminal part of the variable region, an F-actin-binding domain (FABD) (Supplementary Figure 10a), which is important for recruiting CaMKII to Factin [24] . Moreover, CaMKIIβ is capable of bundling Factin, thanks to its actin-binding and association domains [28] (Supplementary Figure 10a) . This bundling feature is achieved by the CaMKII oligomers binding to multiple actin filaments. Interestingly, the removal of the FABD in CaMKIIβ (CaMKIIβ-ΔFABD) or the association domain (CaMKIIβ-Δasso) abrogated the capacity of CaMKIIβ to impair migration (Figs. 4a, b) suggesting that the migration defects are due to the actin-bundling activity of CaMKIIβ. We also studied the contribution of the centrosomal targeting sequence (CTS) within the variable region of CaM-KIIβ. This CTS endows CaMKIIβ with the ability to localize to the centrosome [27] . We overexpressed a mutant in which the CTS was deleted (CaMKIIβ-ΔCTS, Supplementary Figure 10a ) and found that this mutated form of CaMKIIβ impaired radial migration similarly to wild-type CaMKIIβ (Figs. 4a, b) suggesting that the migration defects induced by CaMKIIβ overexpression do not involve the localization of CaMKIIβ to the centrosome.
To further establish the contribution of the FABD and association domains in the regulation of neuronal migration, we performed rescue of CaMKIIβ knockdown neurons by expression of wild-type or mutated CaMKIIβ, refractory to silencing by CaMKIIβ#1 shRNA (marked CaMKIIβ*) (Supplementary Figure 10b) . As expected, the abnormal migratory behavior of CaMKIIβ-silenced neurons was fully corrected by co-delivery of CaMKIIβ* ( Supplementary  Figures 10c and d) , thus demonstrating the specificity of the phenotype. In accordance with our previous experiments, CaMKIIβ*-K43R and CaMKIIβ*-ΔCTS rescued the migration of CaMKIIβ-silenced cortical cells, further suggesting that CaMKIIβ action in the cortex is independent of its kinase activity and its localization to the centrosome. Inversely, CaMKIIβ*-ΔFABD and CaMKIIβ*-Δasso were completely inactive in the CaMKIIβ knockdown rescue assay ( Supplementary Figures 10c and d) , thus confirming that the actin-binding and association domains of CaMKIIβ are critical for its action in the regulation of cortical neuron migration.
Real-time imaging confirmed our previous observations by showing that CaMKIIβ-ΔFABD and CaMKIIβ-Δasso abolished the capacity of CaMKIIβ to impair the multipolar-bipolar conversion (Fig. 4c) and to reduce the migration speed in the CP (Fig. 4d) , where neurons migrate using locomotion. A key feature of this mode of migration is the coordinated movement between the nucleus and the centrosome. To determine whether CaMKIIβ regulates this process, we co-electroporated a centrin-Venus construct together with CaMKIIβ and measured the distance between the centrosome and the tip of the nucleus (Fig. 4e) as an indication of centrosome-nucleus coupling. As shown in Fig. 4f , this distance was increased in CaMKIIβ-expressing neurons (3.3 ± 0.4 µm) compared with control neurons (2.0 ± 0.3 µm), suggesting that CaMKIIβ expression affects radial migration by perturbing the step of locomotion. This was further supported by the increased thickness of the leading process in CaMKIIβ-expressing neurons (2.35 ± 0.15 µm vs. 1.88 ± 0.12 µm in control cells) (Fig. 4g) , another phenotype associated with defective nucleus-centrosome coupling [33, 42] . Interestingly, these two defects disappeared when CaMKIIβ was unable to bind and bundle F-actin (Figs. 4e-g ). Altogether, these data show that CaMKIIβ overexpression alters nucleus-centrosome coupling in locomoting neurons and the actin-bundling activity of CaMKIIβ is responsible for these migration defects. CaMKIIβ might thus control locomotion of projection neurons by acting on the actin filaments, which are particularly enriched in the proximal portion of the leading process.
To determine whether CaMKIIβ acts on dendrites via similar domains, we then implemented a new set of rescue experiments and analyzed the dendritic arborization of electroporated neurons at P14. In a previous study performed in cerebellar neurons [27] , it was shown that the CTS of CaMKIIβ is required for CaMKIIβ regulation of dendrite patterning. We thus performed the rescue experiments with the CaMKIIβ*-ΔCTS mutant, as well as with the CaMKIIβ*-ΔFABD and CaMKIIβ*-Δasso mutants. As shown in Supplementary Figure 11 and in accordance with the literature, CaMKIIβ*-ΔCTS failed to rescue the dendritic defects induced by CaMKIIβ knockdown indicating that the CTS is necessary for CaMKIIβ activity on dendrites. Inversely, CaMKIIβ*-ΔFABD and CaMKIIβ*-Δasso fully compensated the dendrite defects 
Autophosphorylation sites within the FABD control CaMKIIβ action in migrating neurons
Importantly, the binding of CaMKIIβ to the actin cytoskeleton has been shown to be controlled by Ca 2+ signaling [23, 43] . In accordance with the literature, we confirmed that in nascent cortical neurons the interaction of CaMKIIβ with F-actin is almost completely lost after an increase in intracellular Ca 2+ concentration (Fig. 5a) . A recent report further described the mechanisms involved in spines and demonstrated that the activation of CaMKII by Ca 2+ influx results in autophosphorylation of the FABD, detaching CaMKII from F-actin [44] . In this study, a phosphomimetic All D mutant, where all S and T residues within the FABD were changed to aspartic acid (CaMKIIβ-All D), completely lost F-actin-binding activity, demonstrating that phosphorylation at the FABD is necessary and sufficient to prevent the interaction with F-actin. To test whether a similar mechanism was involved in migrating neurons, we electroporated the All D form of CaMKIIβ in the cerebral cortex, as well as a phosphoblock All A mutant, where the same S and T residues were changed to alanine (CaMKIIβ-All A). Although the All A mutant was as efficient as the wild-type to impair radial migration, the All D mutant did not induce any migration defect (Figs. 5b, c) . This result suggests that the detachment of CaMKIIβ from F-actin in migrating neurons is also controlled by phosphorylation sites in the FABD. Furthermore, as the migration defects were abolished with the All D mutant, which is unable to bind to actin, it further reinforces our previous result showing that an excessive binding of CaMKIIβ to the actin cytoskeleton induces migration defects in the developing cerebral cortex. These conclusions were strengthened by rescue experiments. Indeed, CaMKIIβ*-All A was able to rescue the migration of CaMKIIβ-silenced neurons whereas CaMKIIβ*-All D failed to counteract the migration acceleration seen upon CaMKIIβ depletion (Supplementary Figure 12) . Taken together, these data demonstrate that the phosphorylation sites in the FABD control CaMKIIβ function in cortical neuron migration.
CaMKIIβ action in migrating neurons is tightly linked to cofilin activity
We next examined why an excessive actin-binding impairs neuronal migration whereas CaMKIIβ silencing, and thus the absence of F-actin-binding and crosslinking by CaM-KIIβ, promotes migration. Interestingly, F-actin-CaMKIIβ interaction has been shown to limit access of actinregulating proteins, like the actin-depolymerizing cofilin, thereby inhibiting their actions and thus stabilizing F-actin structure [44] . Inversely, the dissociation of CaMKIIβ from F-actin by autophosphorylation permits actin remodeling by actin-regulating proteins [44] . In light of these data, we hypothesized that when we overexpressed CaMKIIβ, we prevented the interaction between cofilin and F-actin and consequently limited the activity of cofilin on actin. To counteract this effect of CaMKIIβ overexpression, we coelectroporated cofilinS3A, a nonphosphorylatable form of cofilin that continuously binds to actin filaments, or wildtype cofilin (cofilinWT). We found that cofilinS3A and cofilinWT are able to rescue the migration defects induced by CaMKIIβ overexpression, partially or totally, respectively (Figs. 6a, b) . In accordance with our initial hypothesis, these data suggest that CaMKIIβ and cofilin competes for F-actin binding. In addition, the overexpression of CaMKIIβ decreased the G/F-actin ratio in P19 cells (Fig. 6c) , which further suggest that CaMKIIβ overexpression might inhibit cofilin-induced actin Inversely, we made the assumption that CaMKIIβ knockdown in migrating neurons favored the access of active cofilin (i.e., non-phosphorylated form of cofilin) to Factin. We thus tried to counteract this effect by overexpressing a phosphomimetic form of cofilin (cofilinS3D). Accordingly, overexpression of cofilinS3D fully rescued the migration of CaMKIIβ-silenced neurons ( Supplementary  Figures 13a-b) . Moreover, because CaMKIIβ knockdown increased significantly the G/F-actin ratio ( Supplementary  Figure 13c) , our results suggest that CaMKIIβ silencing in cortical migrating neurons favors actin remodeling by cofilin, which might promote their movement. A precise balance between CaMKIIβ and cofilin activities is therefore required for proper migration of cortical neurons.
Discussion
In this study, we provide evidence that CaMKIIβ has an essential function in the development of the cerebral cortex. Indeed, we demonstrate that correct levels of CaMKIIβ are required for proper radial migration of projection neurons. In particular, CaMKIIβ controls the conversion between the multipolar and the bipolar stage, as well as the step of locomotion in the CP, two actions, which are dependent on its actin-binding and oligomerization domains. CaMKIIβ regulates neuronal migration in the cerebral cortex: an isoform-specific function Although CaMKIIα and β are the major brain isoforms, only the α isoform has been studied extensively, probably because of its prominent role in synaptic plasticity, learning and memory [20, 21, [45] [46] [47] . CaMKIIβ has often been relegated to a redundant role within heteromeric complexes or as a scaffold responsible for targeting CaMKII enzyme to F-actin in subcellular locations such as dendritic spines [24] . Nevertheless, in systems where both CaMKIIα and β are present, CaMKIIβ has been shown to drive dendrite retraction and pruning [27] and to regulate dendritic spine structure and synapse formation [28, 48] . Here, we define a novel isoform-specific function for CaMKIIβ, in the absence of CaMKIIα, thus demonstrating that CaMKIIβ has a major biological function in the brain. Interestingly, γ and δ isoforms are also expressed in the developing cerebral cortex, especially in the VZ and CP [22] . In addition, both γ and δ are able to bind to F-actin [49] . Although CaMKIIδ bundles actin filaments similarly to CaMKIIβ, γ isoform interaction with F-actin results in a completely different . c Western blot of total, G-and F-actin fractions from P19 cells transfected for 24 h with CaMKIIβ overexpressing or control constructs and d quantification of the G/F-actin ratio from four independent experiments. Mean ± s.e.m.; unpaired two-tailed Student's t-test; **p < 0.01. Scale bar represents 100 µm a. See also Supplementary Figure 13 organization of filaments [49] . Therefore, it will be interesting in future studies to determine whether CaMKIIγ and δ isoforms also contribute to corticogenesis and whether they have similar functions.
CaMKIIβ regulates migration through its action on the actin cytoskeleton Our data obtained with the different mutants (Fig. 4 and Supplementary Figure 10) suggest that CaMKIIβ regulates cortical neuronal migration independently of its kinase activity but through its actin-bundling activity. However we cannot totally exclude the involvement of CaMKIIβ kinase activity. Indeed, the experiment with the phosphomutants (Figs. 5b, c) suggests that the kinase activity of CaMKIIβ is required for FABD autophosphorylation and consequently for the detachment of CaMKIIβ from F-actin. Given this, the catalytically inactive mutant of CaMKIIβ (CaMKIIβ-K43R) might not be able to autophosphorylate FABD and detach from F-actin, thus inducing a more severe phenotype compared with wild-type CaMKIIβ. However, although not significant, migration defects after CaMKIIβ-K43R overexpression were somewhat less pronounced compared with CaMKIIβ wild-type overexpression. This might be due to the incapacity of CaMKIIβ-K43R to phosphorylate various proteins such as RhoGEFs or LIM-kinase, which ultimately leads to actin modification [50] [51] [52] [53] . So CaMKIIβ might regulate the actin cytoskeleton in migrating neurons through kinasedependent and -independent activities.
Our data also indicate that CaMKIIβ impacts actin remodeling. However, it has been demonstrated previously that CaMKIIβ alone has no effect on actin polymerization/ depolymerization [28, 44] . Here we show that the action of CaMKIIβ is tightly linked to cofilin, an actindepolymerizing protein also involved in the regulation cortical neuron migration [52, 53] . The activity of cofilin on the actin cytoskeleton is well known to be markedly altered by phosphorylation at serine 3 [54] . CofilinS3D, a phosphomimetic form of cofilin, hence binds actin filaments with lower affinity than wild-type cofilin and weakly severs actin [55] . Moreover, this mutant may act on endogenous cofilin in a dominant-negative manner, probably by competing for binding to phosphatases that dephosphorylate and thereby activate cofilin [56, 57] . Inversely, cofilinS3A, a non phosphorylable form of cofilin, continuously bind to actin filaments and therefore functions as a constitutive active mutant. By using cofilinS3D and S3A mutants, we were able to rescue the migration defects induced by CaMKIIβ knockdown or overexpression, respectively, thus demonstrating that a fine-tuned balance between CaMKIIβ and cofilin activities is necessary to ensure proper actin remodeling and migration of cortical neurons.
CaMKIIβ: a link between Ca 2+ signaling and the actin cytoskeleton in cortical locomoting neurons Locomotion is a saltatory, discontinuous process whereby neurons undergo periods of active movement interspersed by pauses. Interestingly, Ca 2+ fluctuations have been described in the soma of migrating neurons during these different phases. More precisely, Rakic's group demonstrated that forward movement and stationary state during this process are tightly correlated with the peak and trough of Ca 2+ fluctuation [58, 59] . However as mentioned by the authors in their discussion "It is not well understood how transient elevations of [Ca 2+ ] i control the cell motility. One possibility is that fluctuations of [Ca 2+ ] i regulate the dynamic assembly and disassembly of cytoskeletal elements required for the operation of a force-generating mechanism involved in cell movement". In view of our data and those published in the literature, CaMKIIβ might be one of these elements mediating Ca 2+ action on the cytoskeleton. Indeed, our data suggest that Ca 2+ increase in locomoting neurons might dissociate CaMKIIβ from F-actin allowing actin remodeling by actin-modifying proteins such as cofilin and thus the forward movement. Inversely, when [Ca 2+ ] i decreases, CaMKIIβ might reassociate and bundle F-actin, this might limit access of actin-regulating proteins, thereby inhibiting their actions and stabilizing the actin cytoskeleton, which might lead to a pause. Interestingly, this cyclic regulation of CaMKIIβ and subsequently of the actin cytoskeleton organization by Ca 2+ fluctuations has been recently described in spines, where CaMKIIβ acts as dynamic regulator of F-actin during synaptic plasticity [44] .
Implications for neuropsychiatric and neurodevelopmental disorders
A series of recent studies indicate that CaMKII dysfunction is associated with a wide variety of psychiatric and neurodevelopmental diseases, including depression, schizophrenia, epilepsy and various forms of mental retardation [26, 60] . Interestingly, among these studies, it was shown that CaM-KIIβ expression is significantly elevated in frontal cortex of patients diagnosed with schizophrenia [25] . In addition, an increase of CaMKIIβ expression was found in animal models of schizophrenia such as postnatal maternal deprivation and pubertal stress [61] , as well as amphetamine sensitization [62] .
Here, our findings demonstrate that CaMKIIβ contributes to normal brain development by regulating the migration of cortical neurons and thus further support an important role for this gene in the pathophysiology of neurodevelopmental disorders. In view of these data and as abnormalities in neuronal, migration are thought to cause brain disorders such as schizophrenia [2] , it will be interesting to determine whether deregulation of CaMKIIβ contributes to the pathogenesis of this disease. Moreover, because modification of CaMKIIβ expression is associated with multiple psychiatric illnesses [25, 63, 64] , the identification of the upstream regulation of CaMKIIβ expression would provide a clue as to the original signal potentially leading to brain dysfunction. In conclusion, our study contributes to the understanding of cerebral cortex development and might provide insights into the physiopathology of multiple brain disorders.
